Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| 2025 DEVELOPMENTS | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 2 | 1 |
| CATEGORY DATA | 2 | 1 |
| Table/Chart: 3 | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| SLEEP AIDS IN FINLAND | 3 | 1 |
| Graph - Research Sources | 3 | 1 |
| Sleep Aids in Finland - Category Analysis | 4 | 1 |
| KEY DATA FINDINGS | 4 | 1 |
| 2025 DEVELOPMENTS | 4 | 1 |
| Rising sleep issues and premium innovation drive growth in sleep aids during 2025 | 4 | 1 |
| Orion oyj maintains its lead in sleep aids, but multi-channel players like via naturale gain ground | 4 | 1 |
| SLEEP AIDS IN FINLAND | 5 | 1 |
| PROSPECTS and OPPORTUNITIES | 5 | 1 |
| SLEEP AIDS IN FINLAND | 6 | 1 |
| Intense competition is expected to challenge new entrants, despite Rating demand | 6 | 1 |
| CATEGORY DATA | 6 | 1 |
| Table 1 Sales of Sleep Aids: Value 2020-2025 | 6 | 1 |
| Table 2 Sales of Sleep Aids: % Value Growth 2020-2025 | 6 | 1 |
| Table/Chart: EUR million | 6 | 1 |
| Table/Chart: Tabular Data Analysis | 6 | 1 |
| Table/Chart: % current value growth | 6 | 1 |
| Table/Chart: Table 3 NBO Company Shares of Sleep Aids: % Value 2021-2025 | 6 | 1 |
| SLEEP AIDS IN FINLAND | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| Table/Chart: Table 4 LBN Brand Shares of Sleep Aids: % Value 2022-2025 | 7 | 1 |
| SLEEP AIDS IN FINLAND | 8 | 1 |
| Graph - Table 6 Forecast Sales of Sleep Aids: % Value Growth 2025-2030 | 8 | 1 |
| Table/Chart: EUR million | 8 | 1 |
| Table/Chart: Tabular Data Analysis | 8 | 1 |
| Table/Chart: Table 6 Forecast Sales of Sleep Aids: % Value Growth 2025-2030 | 8 | 1 |
| Consumer Health in Finland - Industry Overview | 9 | 1 |
| EXECUTIVE SUMMARY | 9 | 1 |
| Key trends in 2025 | 9 | 1 |
| Competitive landscape | 9 | 1 |
| SLEEP AIDS IN FINLAND | 10 | 1 |
| Channel developments | 10 | 1 |
| What next for consumer health? | 10 | 1 |
| MARKET INDICATORS | 10 | 1 |
| SLEEP AIDS IN FINLAND | 11 | 1 |
| MARKET DATA | 11 | 1 |
| Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 11 | 1 |
| Table/Chart: Tabular Data Analysis | 11 | 1 |
| Table/Chart: Table 8 Life Expectancy at Birth 2020-2025 | 11 | 1 |
| Table/Chart: Table 9 Sales of Consumer Health by Category: Value 2020-2025 | 11 | 1 |
| Table/Chart: % current value growth | 11 | 1 |
| SLEEP AIDS IN FINLAND | 12 | 1 |
| Table/Chart: Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025 | 12 | 1 |
| Table/Chart: Tabular Data Analysis | 12 | 1 |
| Table/Chart: Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 12 | 1 |
| SLEEP AIDS IN FINLAND | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025 | 13 | 1 |
| SLEEP AIDS IN FINLAND | 14 | 1 |
| Table 14 Distribution of Consumer Health by Format: % Value 2020-2025 | 14 | 1 |
| Table 15 Distribution of Consumer Health by Format and Category: % Value 2025 | 14 | 1 |
| Table/Chart: % retail value rsp | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| SLEEP AIDS IN FINLAND | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| SLEEP AIDS IN FINLAND | 16 | 1 |
| Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 16 | 1 |
| EUR million | 16 | 1 |
| Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| Table/Chart: Note 3: 2025 data is provisional and based on part-year estimates | 16 | 1 |
| SLEEP AIDS IN FINLAND | 17 | 1 |
| APPENDIX | 17 | 1 |
| Otc registration and classification | 17 | 1 |
| Table/Chart: Tabular Data Analysis | 17 | 1 |
| SLEEP AIDS IN FINLAND | 18 | 1 |
| Vitamins and dietary supplements registration and classification | 18 | 1 |
| Self-medication/self-care and preventive medicine | 18 | 1 |
| Disclosure | 19 | 1 |
| Table/Chart: Summary 1 OTC: Switches 2024-2025 | 19 | 1 |
| Table/Chart: Tabular Data Analysis | 19 | 1 |
| Table/Chart: Summary 2 Research Sources | 19 | 1 |
| Disclosure | 20 | 1 |
| Graph - Source: Euromonitor International | 20 | 1 |
| Table/Chart: Tabular Data Analysis | 20 | 1 |
